Matthew Hammond BS, MBA, PhD

Matthew Hammond is a Principal on the Investment Team at RA Capital Management. Matthew’s primary responsibility at RA Capital is to conduct due diligence on biotechnology companies. Prior to this role, Matthew was a Senior Associate on the Landscape Team within the TechAtlas division of RA Capital, where he mapped a number of competitive landscapes in the orphan disease space and performed in-depth analyses of pharma pipelines.
Matthew holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA in Finance from the University of Connecticut. His graduate research investigated immune response after intracerebral hemorrhage.